Search Results 401-410 of 16739 for Proliferation
Learn about the symptoms, diagnosis and treatment of this type of non-Hodgkin lymphoma.
This study is being done to see if daratumumab is safe and effective in the treatment of proliferative glomerulonephritis with monoclonal immune deposits ...
Cyclin D interacts directly with cyclin-dependent kinases 4 and 6 (CDK4/6) in an active protein complex that promotes cell proliferation; and consequently ...
Proliferative glomerulonephritis secondary to dysfunction of the alternative pathway of complement. Clin J Am Soc Nephrol. 2011 May; 6 (5):1009-17 Epub 2011 ...
Taselisib is a PI3K inhibitor. The PI3K pathway is involved is cancer growth. Androgen may cause the growth of tumor cells. Enzalutamide may stop the growth of ...
The purpose of this study is to confirm that adding custirsen to standard first-line docetaxel and prednisone treatment can slow tumor progression in men who ...
... proliferative disorder, myeloma protein, and skin changes), and Waldenstrom macroglobulinemia are ineligible * If a patient develops recurrent/refractory (R ...
Inappropriate activation of Hh pathway signaling and uncontrolled cellular proliferation may be associated with mutations in the Hh-ligand cell surface receptor ...
Mayo Clinic researcher Leland S. Hu, M.D., studies neuro-oncological imaging to diagnose and treat brain tumors, specifically glioblastomas.
An electrophysiology study can show the cause of irregular heart rhythms and guide treatment. Know when it's done and the risks.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.